title: Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease.
authors.affiliation: Department of Ophthalmology, University Medical Center Benjamin Franklin, Freie Universität Berlin, Berlin, Germany.
authors.forename: Lothar
authors.initials: L
authors.lastname: Krause
authors.forename: Julia R
authors.initials: JR
authors.lastname: Turnbull
authors.forename: Necip
authors.initials: N
authors.lastname: Torun
authors.forename: Uwe
authors.initials: U
authors.lastname: Pleyer
authors.forename: Christos C
authors.initials: CC
authors.lastname: Zouboulis
authors.forename: Michael H
authors.initials: MH
authors.lastname: Foerster
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009901:Optic Nerve Diseases / Q000188:drug therapy / Q000209:etiology; D011994:Recombinant Proteins; D013997:Time Factors; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins